Cipla shares in focus today as FDA licence of Patalganga unit suspended for 10 days
Cipla shares ended flat at Rs 1242, rising 0.56% or Rs 6.95 on BSE against the previous close of Rs 1235.20.
Stay updated with breaking news from Cosmetics Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla shares ended flat at Rs 1242, rising 0.56% or Rs 6.95 on BSE against the previous close of Rs 1235.20.
Cipla also said that it wasn't in agreement with the FDA rulings and will appeal against the order to the state government.
Jammu Tawi, Aug 16: A special drive was carried out in Jammu Province wherein surprise inspections of Drug Sale Establishments were carried out under the supervision of Concerned Empowered Authorities. The drive was targeted to ensure that the drugs consisting of habit forming ingredients are strictly sold to the needy patients as per mandate of
(This story has not been edited by THE WEEK and is auto-generated from a PTI
(This story has not been edited by THE WEEK and is auto-generated from a PTI